GRCE

Grace Therapeutics, Inc. Common Stock
GRCE

Overview Fund Activity

24 hedge funds and large institutions have $1.33M invested in Grace Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 11 closing their positions.

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
1
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$227K
2
VF
2
Virtu Financial
New York
$548K
3
Jane Street
3
Jane Street
New York
$60K
4
EDRH
4
Edmond de Rothschild Holding
Switzerland
$60K
5
TSS
5
Two Sigma Securities
New York
$29K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$31K
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
OC
4
Oppenheimer & Co
New York
$0
5
HF
5
HRT Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Cetera Investment Advisers
26
Cetera Investment Advisers
Illinois
– -$5K -313 Closed
AWM
27
AE Wealth Management
Kansas
– -$4K -274 Closed
Walleye Trading
28
Walleye Trading
New York
– -$3K -215 Closed
FWM
29
Frontier Wealth Management
Missouri
– -$3K -208 Closed
ASN
30
Advisory Services Network
Georgia
– -$1K -42 Closed
1
2